personalized care

Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment

Treatment Preferences The exploration of treatment preferences for subcutaneous immunoglobulin (SCIg) among individuals diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP),

Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment Read Post »

Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis

Study Overview The research focuses on chronic inflammatory demyelinating polyneuropathy (CIDP), a neurological disorder characterized by progressive weakness and sensory

Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy – a post-hoc analysis Read Post »

Scroll to Top